In a national study of older Danes who had previously had a fracture and were taking bisphosphonates, the risk of having a serious though rare atypical femoral fracture (AFF) was greater after 3 to 5 ...

The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. Researchers conducted a ...

Development of an Actionable Framework to Address Cancer Care Disparities in Medically Underserved Populations in the United States: Expert Roundtable Recommendations We conducted a retrospective ...

Data suggest a protective association of bisphosphonates against having a kidney stone diagnosis or procedure. Patients receiving bisphosphonates for osteoporosis treatment are less likely to have ...

Please provide your email address to receive an email when new articles are posted on . Compared with oral bisphosphonate use, denosumab use was associated with a 45% lower risk for fractures among ...

ONJ has occurred in one in 100,000 individuals on oral bisphosphonates, while 95% of cases are related to IV bisphosphonate use. Sixty percent of those with ONJ had a recent dental extraction as a ...

Consider this: Your patient needs an extraction but has received oral bisphosphonate therapy. Invasive procedures can go wrong in such cases because bisphosphonate drugs can cause the very rare, but ...

If Sally Field is to be believed, then she really, really likes Boniva, the bone loss drug that she currently shills for in TV commercials. And if Cheryl Ladd is considered a reliable source, then ...

Romosozumab was not associated with increased cardiovascular risks among patients with osteoporosis when compared with bisphosphonate use. Romosozumab does not appear to significantly increase the ...